Production of Recombinant Denileukin Diftitox: Assessment in the Lab-scale Bioreactor

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 42

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_REMJ-7-3_004

تاریخ نمایه سازی: 22 دی 1402

Abstract:

Introduction: Denileukin diftitox is a recombinant immunotoxin composed of truncated diphtheria toxin fused to human interleukin ۲ (DT۳۸۹-IL۲). It is a candidate for protein therapy of lymphoma. This work aims to investigate DT۳۸۹-IL۲ production using a recombinant strain of Escherichia coli in the lab-scale bioreactor. Material and methods: First, the effect of chemical composition in culture medium (the complex and defined) was investigated in DT۳۸۹-IL۲ expression in E.coli BL۲۱ (DE۳) containing pET-IDZ plasmid in shack flask and lab-bioreactor culture. To enrich the carbon source, we added glucose ۶-۸ g/L to the complex culture medium. The composition of the defined medium was enriched by adding amino acids (valine, ۰.۰۵۰۲; phenylalanine, ۰.۰۱۳۲; lysine, ۰.۰۱۸۴; aspartic acid, ۰.۰۱۶; and serine, ۰.۰۲۵۱ g/L). The growth cell was measured by the optical density method and the expression yield was investigated by SDS-PAGE. Results: The maximum growth rate was determined in a modified complex culture medium containing glucose (۶ g/L).  The bacteria growth in the medium was achieved to the optical density of ۵.۵ in the shack flask culture, and under the same condition, the optical density of medium increased to ۱۳ in the bioreactor. Adding amino acids to the defined medium significantly enhanced cell growth and expression of proteins. Also, the optical densities of ۲.۹۵ and ۶.۱ were achieved in the shack-flask and bioreactor culture, respectively. The specific growth rates of bacteria in the complex medium and the defined medium were determined as ۰.۸۹ and ۰.۴۷ h-۱, respectively.  Conclusion: Adding glucose (carbon source) to the complex medium and elemental enrichment by adding amino acids increased biomass production. The growth cell rate in the bioreactor through suitable control of the environmental conditions and proper mixing was higher compared with the shack-flask culture.

Authors

Seyed Morteza Robatjazi

Department of Bioscience and Biotechnology, Malek Ashtar University of Technology, Tehran, Iran.

Sanaz Mahboudi

Department of Bioscience and Biotechnology, Malek Ashtar University of Technology, Tehran, Iran.

Mehdi Zeinoddini

Department of Bioscience and Biotechnology, Malek Ashtar University of Technology, Tehran, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, ...
  • Allahyari H., Heidari S., Ghamgosha M., Saffarian P. and Amani ...
  • Narang AS, Desai DS. Anticancer drug development: unique aspects of ...
  • Saijo N, Tamura T, Nishio K. Strategy for the development ...
  • Wu HC, Chang DK, Huang CT. Targeted therapy of cancer. ...
  • Weiner, LM., Surana, R., Wang, S. Monoclonal antibodies: versatile platforms ...
  • Li YM, Hall WA. Targeted toxins in brain tumor therapy. ...
  • Adams, GP., Weiner, LM. Monoclonal antibody therapy of cancer. Nat. ...
  • Kreitman, RJ. Immunotoxins for Targeted Cancer Therapy. AAPS J. ۲۰۰۶; ...
  • Frankel,AE., Kreitman, RJ. and Sausville, EA. Targeted Toxins, Clin. Can. ...
  • Babavalian E., Zeinoddini M., Saeedinia A.R., Mohammadi R., Xodadadi N. ...
  • Pastan I, Hassan R, Fitzgerald DJ, Kreitman RJ. Immunotoxin therapy ...
  • Foss FM. DAB(۳۸۹)IL-۲ (denileukin diftitox, ONTAK): a new fusion protein ...
  • Figgitt DP, Lamb HM, Goa KL. Denileukin diftitox. Am. J. ...
  • Eklund JW, Kuzel TM. Denileukin diftitox: a concise clinical review. ...
  • Kaminetzky D, Hymes KB. Denileukin diftitox for the treatment of ...
  • Rothen S.A., Sauer S.B. and Witholt, B. Growth Characteristics of ...
  • Shojaosadati S.A., Kolaei S.M.V, Babaeipour V., Farnoud M. Recent advances ...
  • Castrillo J.I., Kaliterna J., Weusthuis R.A., Van J.P., Pronk J.T. ...
  • Aristidou A.A., San K.Y. and Bennett G.N. Modification of Central ...
  • Heydari, M., Robatjazi, SM., Zeinoddini, M. Investigation of the complex ...
  • Bayat S, Zeinoddini M, Azizi A, Khalili MN. Co-solvents effects ...
  • Fong B.A., Wood DW. Expression and purification of ELP-intein-tagged target ...
  • Daniel M., Robert D.R., and Chisti Y. A recombinant vaccine ...
  • Donyapoor F., Zeinoddini M., and Saeedinia A.R. Cloning and Expression ...
  • Woo, J.H., Liu, Y.Y., Stavrou, S. and Neville Jr., D.M. ...
  • Zuppone S., Fabbrini M. S., Vago R. Hosts for Hostile ...
  • نمایش کامل مراجع